Chemical industry – Page 9
-
BusinessChevron and BP cutting thousands of jobs
Oil industry is broadly looking to cut costs, increase oil and gas production and cut renewable investments
-
OpinionFluorine makes you an offer you can’t refuse
What might we do if we had a new, electron-donating equivalent element?
-
ResearchGenerative AI pipeline creates promising antimicrobial peptides
AI model extrapolates beyond training data to predict diverse antimicrobial structures
-
BusinessNew type of painkiller approved in US
Sodium channel blocker prevents nerves transmitting pain signals
-
FeaturePutting the F in pharma
Adding fluorine to drug molecules can be tricky, but is often worthwhile. Rachel Brazil talks to the chemists trying to tame the ninth element
-
ResearchFar more drugs could be taken orally by formulating them with silica nanoparticles
Many more medicines could be made water soluble making taking them easier for patients
-
BusinessDow to cut 1500 jobs as global chemicals industry reshapes
US firm joins other industry heavyweights in shedding jobs to cut costs
-
ResearchMapping metabolite disturbances by drugs
High-throughput metabolomic profiling gives insight into unpredictable drug effects
-
NewsChemical sciences workforce growth could outstrip rest of UK over next 10 years
Royal Society of Chemistry report says support for schools, universities and industry is needed for sector to thrive
-
BusinessNew Purdue bankruptcy deal cuts out Sacklers’ legal immunity
$7.4 billion proposal will fund support for victims of US opioid crisis
-
OpinionMaintaining mental balance
Finding solace from human affairs in the eypiece of a telescope or microscope
-
BusinessEight workers dead in Indian munitions factory explosion
Seven others injured during incident at state-owned explosives plant
-
BusinessJ&J’s Intra-Cellular deal could signal more mega-mergers for 2025
£15 billion deal for neuroscience biotech aims to replace revenues from patent expiries
-
BusinessRed 3 dye banned in US food and drugs
Additive was already banned in US cosmetics and around the world
-
OpinionSharing the burden of contraception could also mean sharing the risk
What if risk assessments for contraception considered the sum of risk to both members of a couple?
-
FeatureOn the trail of the male contraceptive pill
As multiple novel male contraception compounds enter clinical trials, is family planning about to undergo a second revolution? James Mitchell Crow reports
-
OpinionRobots queuing up to fail
Claims of an AI revolution in drug discovery are missing the biggest problem
-
OpinionThe right level of trust in the scientific literature
An overreliance on what’s gone before can hinder innovation
-
NewsMaterials strategy for UK needs chemistry to succeed and create new industries
Ten-year plan proposed by Henry Royce Institute aims to boost productivity and support the circular economy
-
FeatureThe promise of drugs that send proteins to the shredder
Andy Extance charts how research into revolutionary targeted protein degradation therapies is moving from serendipity to strategic discovery